US Patent Litigations are now available. Check here

Explore Medy Tox's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 17, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2692350Jun 28, 2023Lyophilized Preparation Of Botulinum Toxin1
EP3079714Nov 25, 2020Long Lasting Effect Of New Botulinum Toxin Formulations1